efficacy of 15% formic acid on varroa mites in different forms of application

Clicks: 155
ID: 177016
2002
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #64 of 85 articles by views in balkan medical journal

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Varroa destructor is a parasitic mite of the honeybee, Apis mellifera, responsible for reduced honey and brood production, higher bee mortality in winter. Because the resistance to the acaricides and they residues to bee products, alternative products and methods have been used against Varroa. One of this methods is treatment with formic acid. Formic acid induce to Varroa mite in brood and do not leave any residues in products. Concentric formic acid (60-85%) is very effective, but at higher air temperature, it has influence on bee. In the last few years, except concentric formic acid, 15 % formic acid was recommended as control of varroosis. Diluted formic acid (15%) reduced the bee response to treatment. In treatment with 15% formic acid, higher air temperature and different forms of application have positive influence to they function (65 – 95%).
Reference Key
mua2002journalefficacy Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors ;M MUŽA;D KEKEZ;M Dražić;D BUBALO;N Kezić
Journal balkan medical journal
Year 2002
DOI
DOI not found
URL
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.